Dr. Sherif A. Ibrahim (The GLYCANC project Egyptian leader) got fund from DAAD, STDF and EU H2020 to study the role of the cell surface heparan sulfate proteoglycan, Syndecan-1 (Sdc-1), and microRNAs in breast cancer progression. Iam interested in defining distinct molecular signature and deciphering novel molecular mechanisms which governing inflammatory breast cancer (IBC) and its tumor microenvironment with a special focus on the role of Syndecan-1 and cancer stem cells.